Bruker Insider Grants: 25,844 RSUs; 24,430 Options with Four-Year Vesting
Rhea-AI Filing Summary
Bruker Corporation (BRKR) reported equity awards to Executive Vice President and CFO Gerald N. Herman on 08/15/2025 consisting of 25,844 Restricted Stock Units and 24,430 stock options with an exercise price of $36.872. Following the transactions Herman beneficially owns 102,583 shares and 24,430 options. Both the RSUs and the options vest in equal installments on each of the first four anniversaries of the original grant date, and the options become exercisable beginning 08/15/2026 with an expiration date of 08/15/2035. The transactions were reported on a Form 4 under Section 16.
Positive
- 25,844 Restricted Stock Units granted, which align executive incentives with shareholders
- 24,430 stock options granted with a defined exercise price of $36.872
- Vesting schedule in equal installments over four years promotes retention
- Post-transaction beneficial ownership of 102,583 shares indicates meaningful insider stake
Negative
- None.
Insights
TL;DR: Executive equity grants are routine compensation, modestly dilutive and align management with shareholder value.
The reported grants consist of 25,844 RSUs and 24,430 options at an exercise price of $36.872. Vesting over four years phases potential dilution and links compensation to retention and future performance. The option expiration in 2035 provides a long-term incentive window. This disclosure is standard for Section 16 officers and appears to be a compensation-related issuance rather than a sale or disposition.
TL;DR: Equity-based awards to a CFO are consistent with governance practices to align pay and performance.
The structure—RSUs plus time-vesting options—reflects common governance practice to promote retention and align interests with shareholders. Vesting in equal annual installments over four years creates multi-year service incentives. There is no indication in the filing of accelerated vesting or special terms beyond standard schedules. The disclosure meets Section 16 reporting requirements.